Jha Hem C, Vardhan Harsh, Gupta Rishein, Varma Rakesh, Prasad Jagdish, Mittal Aruna
Division of Tissue Culture/Microbiology, Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India.
BMC Infect Dis. 2007 May 30;7:48. doi: 10.1186/1471-2334-7-48.
There is growing evidence that Chlamydia pneumoniae may be involved in the pathogenesis of atherosclerosis, as several studies have demonstrated the presence of the organism in atherosclerotic lesions. C. pneumoniae infections, which are especially persistent infections, have been difficult to diagnose either by serological methods or isolation of the organism from the tissue. Nucleic Acid Amplification tests (NAATs) has emerged as an important method for detecting C. pneumoniae. Inspite of high prevalence of C. pneumoniae specific antibodies in coronary heart disease patients, direct detection of C. pneumoniae in circulating blood of coronary artery disease (CAD) patients by sensitive nucleic acid amplification tests nested PCR (nPCR), multiplex PCR (mPCR) has not been carried out is required. Further correlation of the presence of C. pneumoniae in blood of CAD patients with C. pneumoniae specific IgA and IgG antibodies, which may indicative of the status of infection with the progression of atherosclerosis. This will help in order to prepare strategies for the antibiotic intervention to avoid the progression towards CAD.
Venous blood was obtained from 91 CAD patients and 46 healthy controls. Nucleic acid amplification tests viz. nested-, semi-nested- and multiplex PCR were used for detection of C. pneumoniae. ELISA carried out prevalence of C. pneumoniae specific IgG and IgA antibodies.
29.67% (27/91) patients were positive for C. pneumoniae using nested PCR. The sensitivity and specificity of semi-nested and multiplex PCR were 37.03%, 96.96% and 22.22%, 100% with respect to nested PCR. Positive nPCR patients were compared with presence of C. pneumoniae specific IgA, IgA+IgG and IgG antibodies. Among 27 (29.67%) nPCR C. pneumoniae positive CAD patients, 11(12%) were IgA positive, 13(14.2%) were IgA+IgG positive and only1 (1.1%) was IgG positive. A significant presence of C. pneumoniae was detected in heavy smokers, non-alcoholics and with family histories of diabetes and blood pressure group of CAD patients by nPCR.
The results indicate synergistic association of C. pneumoniae infection and development of CAD with other risk factors. We also detected increased positivity for C. pneumoniae IgA than IgG in nPCR positive CAD patients. Positive nPCR findings in conjunction with persisting high C. pneumoniae specific antibody strongly suggest an ongoing infection.
越来越多的证据表明肺炎衣原体可能参与动脉粥样硬化的发病机制,因为多项研究已证实在动脉粥样硬化病变中存在该病原体。肺炎衣原体感染,尤其是持续性感染,无论是通过血清学方法还是从组织中分离病原体都难以诊断。核酸扩增检测(NAATs)已成为检测肺炎衣原体的重要方法。尽管冠心病患者中肺炎衣原体特异性抗体的患病率很高,但尚未通过敏感的核酸扩增检测嵌套式聚合酶链反应(nPCR)、多重聚合酶链反应(mPCR)对冠状动脉疾病(CAD)患者循环血液中的肺炎衣原体进行直接检测。CAD患者血液中肺炎衣原体的存在与肺炎衣原体特异性IgA和IgG抗体的进一步相关性,这可能表明随着动脉粥样硬化进展的感染状态。这将有助于制定抗生素干预策略以避免向CAD进展。
从91例CAD患者和46例健康对照中采集静脉血。采用核酸扩增检测即嵌套式、半嵌套式和多重聚合酶链反应检测肺炎衣原体。采用酶联免疫吸附测定法检测肺炎衣原体特异性IgG和IgA抗体的患病率。
使用嵌套式聚合酶链反应,29.67%(27/91)的患者肺炎衣原体呈阳性。相对于嵌套式聚合酶链反应,半嵌套式和多重聚合酶链反应的敏感性和特异性分别为37.03%、96.96%和22.22%、100%。将嵌套式聚合酶链反应阳性的患者与肺炎衣原体特异性IgA、IgA+IgG和IgG抗体的存在情况进行比较。在27例(29.67%)嵌套式聚合酶链反应肺炎衣原体阳性的CAD患者中,11例(12%)IgA呈阳性,13例(14.2%)IgA+IgG呈阳性,仅1例(1.1%)IgG呈阳性。通过嵌套式聚合酶链反应在重度吸烟者、不饮酒者以及有糖尿病家族史和高血压家族史的CAD患者组中检测到肺炎衣原体的显著存在。
结果表明肺炎衣原体感染与CAD的发生以及其他危险因素之间存在协同关联。我们还在嵌套式聚合酶链反应阳性的CAD患者中检测到肺炎衣原体IgA的阳性率高于IgG。嵌套式聚合酶链反应的阳性结果与持续高滴度的肺炎衣原体特异性抗体一起强烈提示正在发生感染。